X-FAB Says Demand Has Bottomed as Book-to-Bill Turns Positive, Sizes Data Center Opportunity at $300 Million While Flagging a Financing Gap
Q2 2026 earnings call, July 30, 2026
X-FAB Silicon Foundries used its second-quarter call to argue that the worst of the automotive semiconductor downturn is over, even as the numbers still show revenue declining year-over-year. CEO Damien Macq told analysts that the underlying book-to-bill ratio, stripped of the temporary distortion from the Erfurt end-of-life program, climbed back above 1.0 for the first time since the second quarter of 2024. "We reached the bottom," Macq said, pointing to bookings of $173.3 million, up 2% quarter-on-quarter, and a backlog of $291.8 million. Automotive, which still fell 19% year-over-year to $116 million on continued inventory normalization, nonetheless posted its best book-to-bill in almost two years, a divergence management is treating as the clearest signal yet that the destocking cycle has run its course.
Management was careful not to over-promise on the pace of recovery. Macq noted that X-FAB sits deep in a long automotive supply chain with multiple tiers between the foundry and the OEM, a structure that "can create swings in the demand" and makes near-term forecasting unreliable. The company guided Q3 revenue to $195 million to $205 million with an EBITDA margin of 17% to 20%, a modest sequential step up, but declined to give any Q4 color, saying only that management expects the second half to be stronger than the first and that conversations with its largest customer have been "quite optimistic" about Q3 and Q4.
Data Center Opportunity Quantified for the First Time
The most concrete new disclosure was management's sizing of its data center infrastructure opportunity. X-FAB estimates a long-term annual revenue potential of approximately $300 million from AI-driven data center demand, spanning power conversion, sensing, photonic connectivity, silicon carbide and gallium nitride. That figure is a step-change from where the business sits today: Macq pegged current data center-related revenue, mostly from silicon carbide, photonics and CMOS, at just $20 million to $30 million. He was candid that the timeline to close that gap is uncertain and depends heavily on the trajectory of customers' own data center programs rather than anything X-FAB controls directly. "It is significantly linked to also the success of some of the customers we are interacting with in this domain," he said, adding that new architecture deployment cycles are "driven by multiple dynamics that we do not control directly from an X-FAB perspective." Investors should treat the $300 million figure as a pipeline-based ceiling rather than a near-term revenue bridge.
A Social Media Post Sparked the Stock, Management Downplays It
Analyst Narahari Narasapur asked directly about a wave of recent volatility in X-FAB shares tied to a social media post. Macq's response was notably blunt: the post was "a big surprise to us," and while it touched on real areas of the business, including photonics, wide bandgap and high-voltage CMOS relevant to data centers, "there was a lot of information that was in fact not totally new." He characterized it as a compilation of already-public news that drew connections, some of which the company would not fully endorse, between its actions and large customers. "Nothing was fundamentally wrong in the statement," Macq said, but he stopped short of confirming any of the specific claims, leaving it to "the market to make their own conclusion." The episode underscores how thin newsflow and speculative retail interest can move a stock with limited sell-side coverage, and management's response suggests no material undisclosed catalyst behind the move.
Financing Overhang Emerges as a Real Near-Term Issue
A less flattering disclosure came on the balance sheet. CFO Alba Morganti confirmed that X-FAB's EUR 200 million revolving credit facility, originally signed in 2021, matures in November 2026, and the company has already exercised its one-year extension option. That buys time but does not solve the problem: "Only with the extension of that line, our financial indebtedness won't be sufficient. We won't have enough capacity on credit lines for the future," Morganti said. Management is evaluating a new revolving facility, a Schuldschein loan, or other alternatives, and noted lender appetite was strong when the existing extension was negotiated. Net debt rose to $312.3 million in the quarter, up $20.9 million sequentially, while cash stood at $163.6 million. The quarter also included an $11 million non-cash tax charge tied to the derecognition of deferred tax assets in Malaysia, which hit net income but not cash. With EBITDA margin still running below the top of its 17%-to-20% guided range and capacity utilization at just 60% of the company's roughly $1.3 billion full-capacity model, the financing question is one for investors to watch closely over the next twelve months.
Capacity, Pricing and the Path to 85%-90% Utilization
Macq said utilization ended the second quarter at 60%, well below the 85% to 90% level management considers optimal, and that existing capacity, following the completed Malaysia expansion, should be sufficient for the next two to three years even under a growth scenario. On pricing, he signaled a shift in tone: tightening supply of SOI and 200-millimeter wafers could eventually be passed through, but X-FAB is not yet ready to announce a broad-based increase, preferring case-by-case negotiations that protect customers' market share gains. "New demand is coming in our way, and that will place us in a different situation compared to what we have seen over the past six to nine months," he said.
Chips Act Funding and the Specialization Strategy
X-FAB confirmed it has been awarded EUR 127.4 million under the European Chips Act to expand microsystems and photonics manufacturing in Erfurt, alongside the newly launched Fab4Micro initiative. Management frames this as the anchor of its "specialization strategy," concentrating photonics, MEMS and microfluidics capability in Erfurt while the broader Erfurt end-of-life program remains on track for substantial completion in the first half of 2027. Photonics volume production is still not expected before 2028, and the company pointed to its collaboration with LIGENTEC as opening doors to European and U.S. quantum computing and co-packaged optics customers, though these remain early-stage relationships rather than revenue drivers today.
Segment Detail: Medical Strength, Industrial Volatility, Early Robotics Signal
Medical was the standout segment, up 39% year-over-year to $21 million on pacemaker and ultrasound demand, while industrial revenue fell 13% sequentially to $45.2 million due to order volatility from a major silicon carbide customer. Wide bandgap revenue grew 34% year-over-year to $10.6 million on three new silicon carbide design wins, though Macq acknowledged quarterly demand there "remained somewhat volatile." On robotics, a theme increasingly cited by peers such as Melexis, Macq said the opportunity is broader than a single customer, spanning both automotive and industrial clients globally, including China, though he declined to size it, saying only that visibility would improve over coming quarters.